3-(2'-[18F]fluoroethyl)spiperone, a potent dopamine antagonist:
synthesis, structural analysis and in-vivo utilization in humans
Source: Int J Rad Appl Instrum [A]
1990;41(2):113-129.
Author: Satyamurthy N;Barrio JR;Bida GT;Huang SC;Mazziotta JC;Phelps ME PubMed ID: 2158942
Abstract:
The synthesis of 3-(2'-[18F]fluoroethyl)spiperone (1c), a
radiotracer useful for imaging the brain dopamine receptor system in
vivo using positron emission tomography, is described. Precursors of 1c,
the functional 3-N-alkyl derivatives of spiperone (4), were prepared by
the alkylation of the amide group in spiperone (2a) by 1,2-disubstituted
ethanes under phase transfer conditions. A comprehensive evaluation of
the reaction of the derivatives 4a-h with no-carrier-added
K18F/Kryptofix clearly indicated that the ketalized derivatives 4e-h
were the choice of the precursors for 1c. The i.r., MS and NMR spectral
data suggested that under phase transfer reaction conditions, the amide
nitrogen was preferentially alkylated. To provide a firm basis for
comparison with related analogues, an x-ray analysis was performed on a
single crystal of 3-(2'-fluoroethyl)spiperone (1d). The tomographic
behavior of 1c in human brain tissue was measured for more than 7 h and
was consistent with the labeling of dopamine D-2 receptors